Literature DB >> 15099684

Neuropeptide Y inhibits capsaicin-sensitive nociceptors via a Y1-receptor-mediated mechanism.

J Gibbs1, C M Flores, K M Hargreaves.   

Abstract

Neuropeptide Y (NPY) is expressed in certain primary afferent fibers, is up-regulated in response to tissue injury and is capable of inhibiting nociceptive behavior at the spinal level. However, the spinal mechanism(s) for NPY-evoked antinociception is unknown. In this study, we evaluated the hypothesis that agonists at the NPY Y1 receptor subtype (Y1-R) inhibit exocytosis from the capsaicin-sensitive class of nociceptors. Using in vitro superfusion of rat dorsal spinal cord slices, pre-treatment with the Y1-R agonist [Leu(31)Pro(34)]NPY significantly inhibited capsaicin-evoked release of immunoreactive calcitonin gene-related peptide with an EC(50) value of 10.6 nM. This inhibitory effect was concentration dependent, significantly attenuated by pre-treatment with the Y1 receptor antagonist BIBP3226 and reproduced by synthetic NPY. Examination of adult rat dorsal root ganglia using double immunofluorescent labeling revealed frequent co-localization of Y1 receptor immunoreactivity in vanilloid receptor type 1-immunoreactive neurons, indicating that Y1 agonists may directly modulate the capsaicin-sensitive class of nociceptors. Collectively, these results indicate that NPY is capable of inhibiting capsaicin-sensitive neurons via a Y1 receptor mechanism, suggesting the mechanisms for spinal NPY-induced antinociception is due, at least in part, to inhibition of central terminals of capsaicin-sensitive nociceptors.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15099684      PMCID: PMC4516042          DOI: 10.1016/j.neuroscience.2004.01.044

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  42 in total

1.  Differential regulation of neuropeptide Y receptors in the brains of NPY knock-out mice.

Authors:  P G Trivedi; H Yu; M Trumbauer; H Chen; L H Van der Ploeg; X Guan
Journal:  Peptides       Date:  2001-03       Impact factor: 3.750

2.  Selective mediation of nerve injury-induced tactile hypersensitivity by neuropeptide Y.

Authors:  Michael H Ossipov; En-Tan Zhang; Cristina Carvajal; Luis Gardell; Remi Quirion; Yvan Dumont; Josephine Lai; Frank Porreca
Journal:  J Neurosci       Date:  2002-11-15       Impact factor: 6.167

3.  Reduced antinociception and plasma extravasation in mice lacking a neuropeptide Y receptor.

Authors:  P Naveilhan; H Hassani; G Lucas; K H Blakeman; J X Hao; X J Xu; Z Wiesenfeld-Hallin; P Thorén; P Ernfors
Journal:  Nature       Date:  2001-01-25       Impact factor: 49.962

4.  Role of calcitonin gene-related peptide and its antagonist on the evoked discharge frequency of wide dynamic range neurons in the dorsal horn of the spinal cord in rats.

Authors:  Yi Yu; Thomas Lundeberg; Long Chuan Yu
Journal:  Regul Pept       Date:  2002-01-15

5.  Increased neuropeptide Y (NPY)-like immunoreactivity in rat sensory neurons following peripheral axotomy.

Authors:  S Wakisaka; K C Kajander; G J Bennett
Journal:  Neurosci Lett       Date:  1991-04-01       Impact factor: 3.046

6.  Regulation of galanin and neuropeptide Y in dorsal root ganglia and dorsal horn in rat mononeuropathic models: possible relation to tactile hypersensitivity.

Authors:  T J Shi; J G Cui; B A Meyerson; B Linderoth; T Hökfelt
Journal:  Neuroscience       Date:  1999       Impact factor: 3.590

7.  Localization of neuropeptide Y Y1 receptors in the rat nervous system with special reference to somatic receptors on small dorsal root ganglion neurons.

Authors:  X Zhang; L Bao; Z Q Xu; J Kopp; U Arvidsson; R Elde; T Hökfelt
Journal:  Proc Natl Acad Sci U S A       Date:  1994-11-22       Impact factor: 11.205

8.  [3H]-BIBP3226 and [3H]-NPY binding to intact SK-N-MC cells and CHO cells expressing the human Y1 receptor.

Authors:  P M Vanderheyden; I Van Liefde; J P de Backer; G Vauquelin
Journal:  J Recept Signal Transduct Res       Date:  1998 Jul-Nov       Impact factor: 2.092

Review 9.  Neuropeptide Y: some viewpoints on a multifaceted peptide in the normal and diseased nervous system.

Authors:  T Hökfelt; C Broberger; X Zhang; M Diez; J Kopp; Z Xu; M Landry; L Bao; M Schalling; J Koistinaho; S J DeArmond; S Prusiner; J Gong; J H Walsh
Journal:  Brain Res Brain Res Rev       Date:  1998-05

10.  Effects of intrathecal administration of neuropeptides on a spinal nociceptive reflex in the rat: VIP, galanin, CGRP, TRH, somatostatin and angiotensin II.

Authors:  R A Cridland; J L Henry
Journal:  Neuropeptides       Date:  1988-01       Impact factor: 3.286

View more
  14 in total

1.  Neuropeptide Y Y1 receptor effects on pulpal nociceptors.

Authors:  J L Gibbs; K M Hargreaves
Journal:  J Dent Res       Date:  2008-10       Impact factor: 6.116

2.  Neuropeptide Y modulates effects of bradykinin and prostaglandin E2 on trigeminal nociceptors via activation of the Y1 and Y2 receptors.

Authors:  J L Gibbs; A Diogenes; K M Hargreaves
Journal:  Br J Pharmacol       Date:  2006-12-04       Impact factor: 8.739

3.  Behavioral and anatomical characterization of the bilateral sciatic nerve chronic constriction (bCCI) injury: correlation of anatomic changes and responses to cold stimuli.

Authors:  Sukdeb Datta; Koel Chatterjee; Robert H Kline; Ronald G Wiley
Journal:  Mol Pain       Date:  2010-01-27       Impact factor: 3.395

4.  Intrathecal neuropeptide Y reduces behavioral and molecular markers of inflammatory or neuropathic pain.

Authors:  A B Intondi; M N Dahlgren; M A Eilers; B K Taylor
Journal:  Pain       Date:  2007-10-31       Impact factor: 6.961

Review 5.  Spinal inhibitory neurotransmission in neuropathic pain.

Authors:  Bradley K Taylor
Journal:  Curr Pain Headache Rep       Date:  2009-06

6.  Neuropeptide Y tonically inhibits an NMDAR➔AC1➔TRPA1/TRPV1 mechanism of the affective dimension of chronic neuropathic pain.

Authors:  Weisi Fu; Caitlin R Wessel; Bradley K Taylor
Journal:  Neuropeptides       Date:  2020-01-24       Impact factor: 3.286

7.  Y1 receptor knockout increases nociception and prevents the anti-allodynic actions of NPY.

Authors:  K E Kuphal; B Solway; T Pedrazzini; B K Taylor
Journal:  Nutrition       Date:  2008-09       Impact factor: 4.008

8.  Inflammation enhances Y1 receptor signaling, neuropeptide Y-mediated inhibition of hyperalgesia, and substance P release from primary afferent neurons.

Authors:  B K Taylor; W Fu; K E Kuphal; C-O Stiller; M K Winter; W Chen; G F Corder; J H Urban; K E McCarson; J C Marvizon
Journal:  Neuroscience       Date:  2013-10-31       Impact factor: 3.590

9.  An NPY Y1 receptor antagonist unmasks latent sensitization and reveals the contribution of protein kinase A and Epac to chronic inflammatory pain.

Authors:  Weisi Fu; Tyler S Nelson; Diogo F Santos; Suzanne Doolen; Javier J P Gutierrez; Na Ye; Jia Zhou; Bradley K Taylor
Journal:  Pain       Date:  2019-08       Impact factor: 7.926

Review 10.  Targeting spinal neuropeptide Y1 receptor-expressing interneurons to alleviate chronic pain and itch.

Authors:  Tyler S Nelson; Bradley K Taylor
Journal:  Prog Neurobiol       Date:  2020-08-07       Impact factor: 11.685

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.